GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jerusalem Pharmaceutical Co (XPAE:JPH) » Definitions » Cyclically Adjusted Book per Share

Jerusalem Pharmaceutical Co (XPAE:JPH) Cyclically Adjusted Book per Share : $3.44 (As of Dec. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Jerusalem Pharmaceutical Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Jerusalem Pharmaceutical Co's adjusted book value per share for the three months ended in Dec. 2024 was $3.922. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.44 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Jerusalem Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-05-29), Jerusalem Pharmaceutical Co's current stock price is $3.90. Jerusalem Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $3.44. Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.13.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Jerusalem Pharmaceutical Co was 1.20. The lowest was 0.90. And the median was 1.10.


Jerusalem Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Jerusalem Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jerusalem Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Jerusalem Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 3.52 3.27 3.44

Jerusalem Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.27 3.34 3.37 3.40 3.44

Competitive Comparison of Jerusalem Pharmaceutical Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


;
;

Jerusalem Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jerusalem Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=3.922/133.1571*133.1571
=3.922

Current CPI (Dec. 2024) = 133.1571.

Jerusalem Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201503 2.048 99.621 2.737
201506 2.074 100.684 2.743
201509 2.087 100.392 2.768
201512 2.084 99.792 2.781
201603 2.109 100.470 2.795
201606 2.072 101.688 2.713
201609 2.182 101.861 2.852
201612 2.207 101.863 2.885
201703 2.404 102.862 3.112
201706 2.445 103.349 3.150
201709 2.503 104.136 3.201
201712 2.513 104.011 3.217
201803 2.761 105.290 3.492
201806 2.581 106.317 3.233
201809 2.678 106.507 3.348
201812 2.556 105.998 3.211
201903 2.778 107.251 3.449
201906 2.749 108.070 3.387
201909 2.748 108.329 3.378
201912 2.902 108.420 3.564
202003 2.944 108.902 3.600
202006 2.828 108.767 3.462
202009 2.980 109.815 3.613
202012 3.296 109.897 3.994
202103 3.231 111.754 3.850
202106 3.302 114.631 3.836
202109 3.360 115.734 3.866
202112 3.693 117.630 4.180
202203 3.695 121.301 4.056
202206 3.380 125.017 3.600
202209 3.420 125.227 3.637
202212 3.570 125.222 3.796
202303 3.631 127.348 3.797
202306 3.549 128.729 3.671
202309 3.521 129.860 3.610
202312 3.769 129.419 3.878
202403 3.690 131.776 3.729
202406 3.571 132.554 3.587
202409 3.703 133.029 3.707
202412 3.922 133.157 3.922

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Jerusalem Pharmaceutical Co  (XPAE:JPH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.90/3.44
=1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Jerusalem Pharmaceutical Co was 1.20. The lowest was 0.90. And the median was 1.10.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Jerusalem Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Jerusalem Pharmaceutical Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Jerusalem Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Nablus Street, Jerusalem Pharmaceuticals Company Buliding, Al Bireh Industrial Zone, Al Bireh, PSE, 3570
Jerusalem Pharmaceutical Co is engaged in developing, manufacturing and marketing of human pharmaceuticals products. It also produces detergent, cosmetic, personal and home care products, veterinary and agricultural products. The company operates in Jordan, Algeria, the Middle East, and North Africa Region. Its product portfolio contains more than 300 pharmaceutical products in various dosage forms including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, ointments, as well as ear and nose drops and solutions.

Jerusalem Pharmaceutical Co Headlines

No Headlines